DCPH
Deciphera Pharmaceuticals Inc
Price:  
25.59 
USD
Volume:  
1,596,090.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

DCPH Relative Valuation

-275.5%
Upside

As of 2025-07-01, the Relative Valuation of Deciphera Pharmaceuticals Inc (DCPH) is (44.92) USD. This relative valuation is based on P/E multiples. With the latest stock price at 25.59 USD, the upside of Deciphera Pharmaceuticals Inc based on Relative Valuation is -275.5%.

The range of the Relative Valuation is (36.55) - (50.11) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 15.1x - 22.8x 19.0x
Forward P/E multiples 16.6x - 27.1x 21.8x
Fair Price (36.55) - (50.11) (44.92)
Upside -242.8% - -295.8% -275.5%
25.59 USD
Stock Price
(44.92) USD
Fair Price

DCPH Relative Valuation - Historical P/E Data

Date P/E